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Adult neural stem cells (NSCs) are defined by their
inherent capacity to self-renew and give rise to neu-
rons, astrocytes, and oligodendrocytes. In vivo, how-
ever, hippocampal NSCs do not generate oligoden-
drocytes for reasons that have remained enigmatic.
Here, we report that deletion of Drosha in adult den-
tate gyrus NSCs activates oligodendrogenesis and
reduces neurogenesis at the expense of gliogenesis.
We further find that Drosha directly targets NFIB to
repress its expression independently of Dicer andmi-
croRNAs. Knockdown of NFIB in Drosha-deficient
hippocampal NSCs restores neurogenesis, suggest-
ing that the Drosha/NFIB mechanism robustly pre-
vents oligodendrocyte fate acquisition in vivo. Taken
together, our findings establish that adult hippocam-
pal NSCs inherently possess multilineage potential
but that Drosha functions as a molecular barrier pre-
venting oligodendrogenesis.
INTRODUCTION
Somatic stem cells can generate progeny throughout life, but
their fates are usually restricted, and they generate specific cell
types in their respective tissue. Active adult neural stem cells
(NSCs) are present in two regions of the brain: the subventricular
zone (SVZ) of the lateral ventricles and the subgranule zone of the
hippocampal dentate gyrus (DG) (Ihrie and Alvarez-Buylla, 2011;
Kriegstein and Alvarez-Buylla, 2009). Although both SVZ and DG
NSCs are multipotent, they generate specific neuron types. SVZ
NSCs become fate restricted during embryonic development
and generate multiple interneuron populations from topological
locations in the lateral ventricle wall (Merkle et al., 2007). DG
NSCs produce only granule neurons, which contribute to cogni-
tion, and loss or dormancy of stem cells during aging can result in
psychological disorders and disease (Kronenberg et al., 2003;
Petrus et al., 2009; Santarelli et al., 2003; Steiner et al., 2008).
Whereas SVZ NSCs make a significant number of oligodendro-
cytes (Hack et al., 2004; Menn et al., 2006), new oligodendro-cytes are normally not produced in the adult DG (Bonaguidi
et al., 2011; Encinas et al., 2011; Lugert et al., 2010). In vitro,
DG NSCs also rarely produce oligodendrocytes, although oligo-
dendrocytic differentiation can be induced by their co-culture
with neurons and in vivo by inactivation of the Neurofibromin 1
gene or reprogramming with the transcription factor Ascl1
(Braun et al., 2015; Jessberger et al., 2008; Song et al., 2002;
Suh et al., 2007; Sun et al., 2015). This suggests an intrinsic
and niche-independent fate restriction of DGNSCs that prevents
oligodendrocyte formation. How DG NSC potency and particu-
larly oligodendrocytic fate are restricted remains unclear.
Drosha is part of the microRNA (miRNA) microprocessor (Ha
and Kim, 2014). However, Drosha can also cleave and directly
destabilize mRNAs encoding proteins that regulate cell fate de-
cisions (Chong et al., 2010; Han et al., 2009; Knuckles et al.,
2012; Macias et al., 2012). During embryonic development, Dro-
sha maintains embryonic NSCs in an undifferentiated, multipo-
tent state by targeting and cleaving the mRNA of the proneural
factor Ngn2 (Knuckles et al., 2012). This non-canonical function
of Drosha does not require Dicer or miRNAs, and is a rapid
mechanism for fate regulation.
Here, we examined how Drosha is involved in the regulation of
DG NSC fate. We found that Drosha controls DG NSC mainte-
nance and cell fate acquisition through a non-canonical regula-
tion of the transcription factor nuclear factor IB (NFIB). We
show that NFIB is required for the oligodendrocytic commitment
by DG NSCs and propose that Drosha promotes neurogenesis
and inhibits oligodendrocyte fate acquisition in the hippocampus
by repressing NFIB.
RESULTS
Drosha Deletion from Adult DG NSCs Impairs
Neurogenesis
NSCs in the DG of the adult mouse are Notch dependent and ex-
press the Notch targetHes5 (Lugert et al., 2010, 2012). Drosha is
expressed by most cells in the DG, including GFAP+ and Hes5+
radial NSCs (Figures S1A and S1B). To address the functions of
Drosha in neurogenic DG NSCs, we treated Hes5::CreERT2 mice
carrying floxed Drosha (Drosha cKO) or wild-type (wt) Drosha
(ctrl) alleles with tamoxifen (TAM) and followed cell fate by line-
age tracing (Rosa26-CAG::EGFP) (Figures 1A and S1A) (Lugert
et al., 2012). Twenty-one days after TAM administration, Hes5+Cell Stem Cell 19, 1–10, November 3, 2016 ª 2016 Elsevier Inc. 1
Figure 1. Drosha Deletion from Adult DG NSCs Impairs Neurogenesis In Vivo
(A) TAM induction regime and genotypes of Hes5::CreERT2 mice.
(B and C) GFP+Sox2+ NSCs (yellow arrowheads) in the DG of control (B) and Drosha cKO (C) animals at day 21.
(D and E) Proliferating cells (PCNA+; white arrowheads) and DCX+ neuroblasts in control (D) and Drosha cKO (E) animals at day 21.
(F) Quantification of GFP+Sox2+S100b NSCs, proliferating GFP+PCNA+ progenitors and newly generated neuroblasts GFP+DCX+ in Drosha cKO and control
animals at day 21 (control, n = 5; Drosha cKO, n = 5). Two-sided Student’s t test: *p < 0.05, **p < 0.01.
(G) Quantification of radial GFP+GFAP+ NSCs and DCX+ neuroblasts in Drosha cKO and control animals at day 100 (control, n = 5; Drosha cKO, n = 5). Two-sided
Student’s t test: **p < 0.01, ***p < 0.001.
(H and I) GFP+DCX+ neuroblasts in control (H) and Drosha cKO (I) animals at day 100.
(J and K) GFP+GFAP+ cells in control (J) and Drosha cKO (K) animals at day 100 (arrows in J; GFAP+ radial process).
Data are mean ± SEM. The scale bars represent 20 mm in (B)–(E), (J), and (K) and 50 mm in (H) and (I). See also Figure S1 and Table S1.
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fewer cells compared with controls (Figures S1B–S1D). Further-
more, the number of radial GFAP+, Sox2+, and mitotic (PCNA+)
NSC/progenitors and neuroblasts (DCX+) was reduced in Drosha
cKO animals (Figures 1B–1F and S1E). Decreased neurogenesis
persisted in Drosha cKO animals at 100 days, and the reduction
in newborn neurons (GFP+NeuN+) was accompanied by an in-
crease in S100b+ parenchymal astrocytes compared with con-
trols (Figures 1G–1I and S1F–S1J). In addition, GFAP+ putative
radial NSCs were lost in Drosha cKO animals (Figures 1G, 1J,
and 1K). Together these data suggest that Drosha is required
for NSC maintenance and promotes neurogenesis in the DG at
the expense of gliogenesis.
Quiescent DG NSCs activate, proliferate, and produce neuro-
blasts in response to seizures (Hu¨ttmann et al., 2003; Sierra et al.,
2015; Steiner et al., 2008). We addressed whether NSC-like pro-
genitors remain in the Drosha cKO and can still respond to acti-
vating stimuli. We administered epileptogenic kainic acid (KA) to
induce seizures in Hes5::CreERT2 Drosha cKO and control mice
21 days after TAM induction (Figure S1K). Whereas KA induced2 Cell Stem Cell 19, 1–10, November 3, 2016proliferation and an increase in neuroblasts in control animals
(Figures S1L and S1M), neither proliferation (PCNA+) nor neuro-
blast (DCX+) production was increased following KA treatment of
Drosha cKOmice (Figures S1L andS1N). This suggests that Dro-
sha cKOdiminishes the DGNSC pool and compromises progen-
itor reactivation.
Drosha cKO Induces Oligodendrocyte Commitment
of NSCs
To examine whether Drosha controls neurogenesis by acting on
quiescent NSCs, we ablated Drosha specifically in radial GFAP+
NSCs by stereotactic infection with adenoviruses expressing
Cre-recombinase under the control of the gfap promoter (ad-
eno-gfap::Cre) (Figure S2A) (Merkle et al., 2007). Six days post-
infection (dpi), most GFP-labeled, adeno-gfap::Cre-infected
cells in the subgranular zone in control mice were GFAP+ puta-
tive radial NSCs (Figures S2B–S2D). Twenty-one days post-
infection, adeno-gfap::Cre-infected NSCs had generatedmitotic
(PCNA+) progenitors and neuroblasts (DCX+) in control animals,
but Sox2+ and PCNA+ progenitors were almost absent, and
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http://dx.doi.org/10.1016/j.stem.2016.07.003newly formed neuroblasts were reduced in Drosha cKO animals
(Figures 2A–2E). Therefore, Drosha cKO DG NSCs lose stem cell
potential, demonstrating that Drosha is essential for NSC main-
tenance and neurogenesis.
DG NSCs normally generate glutamatergic granule neurons
and astrocytes but not oligodendrocytes (Bonaguidi et al.,
2011). Following adeno-gfap::Cre-mediated Drosha cKO, a sig-
nificant number of the newborn cells expressed Olig2 and
Sox10, markers of oligodendrocyte progenitor cells (OPCs) (Fig-
ures 2D–2G). Similarly, we observed newly generated Sox10+,
Olig2+, and NG2+ OPCs in Hes5::CreERT2 Drosha cKO animals
(Figures S2E–S2G). Thus, Drosha cKO induces a fate switch in
DG NSCs to oligodendrocytes.
We performed clonal analysis of Hes5::CreERT2 Drosha cKO
NSC fate. Two days after low-dose TAM induction, labeled
NSCs were sparse in the DG (mean distance between clones =
184.3 ± 17.2 mm; Figures S2H and S2I). Twenty-one days post-
TAM, 6 of the 41 clones examined in Drosha cKO animals con-
tained OPCs but none in the controls (Figures 2H, 2I, S2J, and
S2K). Interestingly, 1 clone contained neuroblasts, astrocytes,
and oligodendrocytes, indicating tri-lineage potential of Drosha
cKO NSC in vivo (Figure 2H).
We addressed whether Drosha controls oligodendrocyte pro-
duction from mitotic GFAP stem/progenitor cells. We infected
dividing cells in the DG with a Cre-expressing retrovirus. We
did not see oligodendrocyte formation in the Drosha cKO after
retro-Cre virus infection, and active progenitors continued to
generate neuroblasts (Figures S2L and S2M). These data sug-
gest that Drosha deletion induces a fate shift in the quiescent
NSC pool to oligodendrocyte production but not in active
NSC/progenitors.
Dicer regulates miRNA maturation downstream of Drosha.
To investigate whether Drosha regulates oligodendrocyte
commitment of NSCs via miRNAs, we deleted Dicer (Dicer
cKO) from radial DG NSCs with the adeno-gfap::Cre virus (Fig-
ure S2A). Dicer cKO did not affect the number of Sox2+ pro-
genitors (data not shown) and caused a minor decrease in
neuroblasts, consistent with the role of Dicer in neuronal sur-
vival and maturation (Figures 2G, S2N, and S2O) (Davis
et al., 2008). Unlike Drosha cKO, Dicer cKO did not induce oli-
godendrocytic differentiation of DG NSCs (ctrl versus Dicer
cKO, p = 0.56; Figures 2F and 2G). Therefore, Drosha but
not Dicer inhibits oligodendrocyte differentiation of adult DG
NSCs in vivo, indicating that the mechanism of induced fate
switching caused by the loss of Drosha does not primarily
involve miRNAs.
Drosha cKODGNSCsProduceOligodendrocytes In Vitro
To investigate the mechanisms of Drosha-regulated NSC fate
acquisition, we generated a self-renewing DG NSC culture sys-
tem that recapitulates in vivo features of neurogenesis including
expression of the progenitor markers Sox2 and BLBP (Fig-
ure S2P). Upon growth factor removal (FGF2/EGF), DG
NSCs differentiated into neurons and astrocytes but not oligo-
dendrocytes, indicating conserved intrinsic cell fate restriction
(Figure S2Q; data not shown) (Bonaguidi et al., 2011; Lugert
et al., 2010). We cultured DG NSCs from adult Droshafl/fl,
Dicerfl/fl, and Droshawt/wtDicerwt/wt (control) animals that carried
the Rosa26-CAG::EGFP Cre reporter. Following adeno-Cre viraltransduction, we investigated the effects of Drosha and Dicer
cKO (Figures S2R and S2S). Two days post-infection, BLBP+
progenitors were reduced in the Drosha cKO compared with
control and Dicer cKO cultures, similar to the reduction in pro-
genitors after Drosha ablation in vivo (Figures 2J–2M). Both
differentiated Drosha cKO and Dicer cKONSCs generated fewer
neurons in vitro (Figures 2M and S2T–S2V). However, we
observed an increase in apoptotic cells (cleaved Caspase3+) in
the Dicer cKO cultures compared with Drosha cKO and control,
confirming that Dicer is crucial for neuronal survival and
providing an explanation for the reduction in neurons in its
absence (Figure S2W). Drosha cKO induced an increase in
NG2+ OPCs in the cultures and this at the expense of neuron
and astrocyte production (Figures 2K, 2M, and S2X). Dicer
cKO induced a slight but not significant increase in NG2+
OPCs in the cultures (ctrl versus Dicer cKO, p = 0.27; Figures
2L and 2M). Hence, DG NSCs retain a cell-intrinsic bias against
oligodendrocyte differentiation in vitro, and Drosha controls this
fate decision.We sorted Drosha cKO, Dicer cKO, and control DG
NSCs 48 hr after adeno-Cre virus infection in vitro and deter-
mined the expression profiles of 381 miRNAs by microarray.
Two hundred sixty miRNAs were detected in control DG NSCs
(mean Ct values < 32), and their levels were not significantly
changed 48 hr after Drosha cKO (R2 = 0.81; Figure S2Y), even
though the phenotypes were well established by this time. Dicer
cKO resulted in moderate changes in miRNA levels after 48 hr
(R2 = 0.66; Figure S2Z), although Dicer cKONSCs did not display
an obvious phenotype at this time. Hence, Drosha cKO did not
cause major global changes in miRNA levels, and any changes
were less than in Dicer cKO DG NSCs. These data support
that the mechanism of Drosha suppression of oligodendrocyte
production by DG NSCs is independent of Dicer and miRNAs.
Drosha Binds and Cleaves the NFIB mRNA Regulating
Expression
Drosha can bind and cleave hairpin loops in mRNAs (Chong
et al., 2010; Han et al., 2009; Knuckles et al., 2012; Macias
et al., 2012). In silico analysis (Evofold) (Pedersen et al., 2006) re-
vealed two evolutionarily conserved hairpins in the mRNA of
NFIB, a short 20-base hairpin in the 50 UTR (50 UTR HP) and a
longer hairpin of 83 bases in the 30UTR (30 UTR HP) (Figure 3A).
NFIB plays roles in the development of glial cells and myelin
tracts (Barry et al., 2008; Deneen et al., 2006; Harris et al.,
2015; Kang et al., 2012; Steele-Perkins et al., 2005). To examine
whether Drosha binds directly to NFIB mRNA in DG NSCs, we
performed cross-linked immunoprecipitation (CLIP) for endoge-
nous Drosha protein and examined the bound RNAs (Figures
S3A and S3B). NFIB mRNA cross-linked immunoprecipitated
with Drosha from DG NSCs, as did the known target DGCR8
mRNA (Figures 3B and S3B) (Han et al., 2009; Knuckles et al.,
2012).
In order to address whether either of the two NFIB mRNA hair-
pins convey Drosha association, we placed the 50 UTRHP and 30
UTR HP into the SV40 30 UTR downstream of the Renilla Lucif-
erase (rLuc) coding region of the psiCheck reporter vector (Fig-
ure 3C). We expressed 50 UTR HP and 30 UTR HP containing
rLucmRNAs in N2a cells and performed CLIP to address binding
by Drosha. Both the 50 UTR HP and 30 UTR HP of NFIB bound to
Drosha more efficiently than the SV40 30 UTR sequence aloneCell Stem Cell 19, 1–10, November 3, 2016 3
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are bound by Drosha.
We evaluated whether Drosha cleaves the NFIB hairpins by
in vitro processing assays (Figure 3E) (Lee and Kim, 2007).
Incubation of in vitro transcribed NFIB 30 UTR RNA with purified
Flag-tagged Drosha resulted in cleavage and generation of RNA
fragments (Figure 3F). NFIB 50 UTR HP was not cleaved in vitro,
suggesting that, although bound, it is not processed by Drosha
(Figure S3C). We assessed whether fragmented NFIB mRNAs
were present in DG NSCs in vivo by 50 rapid amplification of
cDNA ends (50RACE). Multiple NFIB mRNAs fragmented in the
vicinity of the 30 UTR HP were detected in wt NSCs (Figure S3D).
Fragmented NFIB transcripts were not detected in Drosha cKO
NSCs, supporting that NFIB mRNA fragmentation at the 30
UTR HP is dependent on Drosha (Figure S3D). Sequencing
andmapping of 48 independent clones of the NFIB 50RACE frag-
ments supported the in vitro processing analysis (Figures 3F and
S3D). The multiple fragmented RNA species suggest that either
Drosha processing of the 30 UTRHP is not as accurate as its pro-
cessing of a pri-miRNA RNA or additional ribonucleases may be
associated with the Drosha complex, and these cleave the RNAs
further. We analyzed changes in NFIB RNA fragmentation in
sorted NSCs following Drosha cKO compared with control by
qRT-PCR over the 30 UTRHP. Drosha cKO increased the relative
levels of non-cleaved NFIB transcripts, confirming the Drosha-
dependent destabilization of NFIB RNAs in vivo (Figure 3G).
To evaluate whether Drosha affects translation of NFIB 30 UTR
HP mRNAs, we performed Luciferase assays in cultured adult
DGNSCs (Figure S3E). Drosha cKO increased Luciferase activity
of an NFIB 30 UTR HP containing synthetic mRNA (Figure S3F).
Surprisingly, Dicer cKO also increased translation of the NFIB
30 UTR HP containing Luciferase mRNA by an unknown mecha-
nism, indicating that under these experimental conditions, Dicer
can also regulate NFIB 30 UTR HP containing mRNAs.
Drosha interaction with hairpins in mRNAs can result in desta-
bilization of the transcripts (Han et al., 2009; Knuckles et al.,
2012). We isolated Hes5::CreERT2 Drosha cKO and Hes5::
CreERT2 control (Droshawt/wt) DG NSCs by fluorescence-acti-
vated cell sorting (FACS) based on GFP expression from the
Cre-activated Rosa26-CAG::EGFP locus following acute induc-
tionwith TAM (Figure S3G). DroshamRNA levels were reduced in
Drosha cKO cells compared with controls (Figure S3G). Interest-
ingly, NFIB mRNA levels were increased in Drosha cKO NSCs,
suggesting that Drosha suppresses NFIB mRNA expression inFigure 2. Drosha Deletion from DG NSCs Induces Oligodendrocyte Fa
(A and B) GFP+Sox2+progenitors and GFP+PCNA+ mitotic cells in control (A) and
(C and D) GFP+DCX+ neuroblasts and GFP+Olig2+ oligodendrocytes in control (C
(E) Quantification of GFP+Sox2+, GFP+PCNA+ progenitors and GFP+Olig2+ olig
infection (control, n = 3; Drosha cKO, n = 3) Two-sided Student’s t test: *p < 0.0
(F) GFP+Sox10+ oligodendrocytes in Drosha cKO and Dicer cKO animals.
(G) Quantification of GFP+DCX+ neuroblasts and GFP+Sox10+ oligodendrocytes u
n = 3). ANOVA with Bonferroni post hoc test: *p < 0.05, **p < 0.01.
(H) Tripotent clone derived from a single Drosha cKO NSC. A, astrocyte; N, neur
(I) Quantification of clone composition in control and Drosha cKO (control clone
***p < 0.001.
(J–L) GFP+BLBP+ and GFP+NG2+ expression in cultured control (J), Drosha cKO
(M) Quantification of neural lineage marker expression by adeno-Cre-infected (GF
Dunn post hoc test: *p < 0.05, **p < 0.01.
Data are mean ± SEM. The scale bars represent 20 mm. See also Figure S2 andDG NSCs in vivo (Figure S3G). As cultured DG NSCs retain Dro-
sha function and blockade of oligodendrocyte differentiation, we
speculated that Drosha-dependent regulation of NFIB should
also be present in vitro. We infected DG NSCs in vitro with
adeno-Cre virus and isolated Drosha cKO and control NSCs
by FACS 2 dpi (Figure S3H). NFIB and Sox10 mRNA levels
were increased in cultured Drosha cKO but not in Dicer cKO
NSCs (Figure S3H). Therefore, Drosha regulates NFIB mRNA
levels in DG NSCs in vivo and in vitro.
Drosha cKO-Induced Oligodendrocytic Differentiation
Depends on NFIB
WeaddressedwhetherNFIB is sufficient todriveoligodendrogen-
esis fromadult DGNSCs.OverexpressedNFIB increasedSox10+
andNG2+OPCs inDGNSCculturesandhadanegative impact on
neurogenesis (Figures 4A and S4A–S4E). Therefore, expression
of NFIB is sufficient to induce programming of DG NSCs to
oligodendrocytes. We addressed whether NFIB is required for
the Drosha cKO-induced oligodendrocyte differentiation of
NSCs. We ablated Drosha from DG NSCs in vitro with adeno-
Cre viruses and simultaneously prevented NFIB mRNA accumu-
lation by knockdown using specific endoribonuclease-prepared
small interfering RNAs (esiRNAs) (Figure 4B). Twenty-four hours
after esiRNA transfection, NFIB mRNAs were undetectable in
DG NSCs compared with cells transfected with a control rLuc
esiRNA (Figure S4F). Neither esiRNA rLuc nor esiRNA NFIB
expression affected the differentiation of control DG NSCs (Fig-
ures 4C, 4D, S4G, and S4H). As expected, most Drosha cKO
NSCs transfected with the esiRNA rLuc differentiated into NG2+
OPCs (Figures 4C and 4E). In contrast, NFIB knockdown reduced
NFIB expression and decreased oligodendrocytic differentiation
of Drosha cKO cells (Figures 4C and 4F). Like their control coun-
terparts, NFIB knockdownDroshacKONSCsadopteda neuronal
fateor remainedasprogenitors (Figures4Gand4H).Thus,Drosha
negatively regulates DG NSC differentiation toward an oligoden-
drocytic fate by suppressing NFIB mRNA levels (Figure S4I).
UponDroshacKO, inhibitionofNFIB is released, andanoligoden-
drocytic differentiation program is activated (Figure S4J).
DISCUSSION
Adult NSC identity is orchestrated by complex regulatory
gene networks and neurogenic niche microenvironments.
Post-transcriptional modifications add an additional level ofte Commitment
Drosha cKO (B) animals at day 21 post-adeno-gfap::Cre virus infection.
) and Drosha cKO (D) animals at day 21.
odendrocytes in control and Drosha cKO day 21 after adeno-gfap::Cre virus
5, **p < 0.01.
pon Drosha cKO and Dicer cKO (control, n = 3; Drosha cKO, n = 3; Dicer cKO,
on; O, oligodendrocyte; R, radial NSC.
s, n = 28; Drosha cKO clones, n = 41). Two-sided Student’s t test: *p < 0.05,
(K), and Dicer cKO (L) NSCs 2 dpi with adeno-Cre virus.
P+) control, Drosha cKO, and Dicer cKO NSCs 2 dpi (n = 4). Kruskal-Wallis with
Tables S2 and S3.
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Figure 3. Drosha Binds and Cleaves NFIB mRNA in DG NSCs
(A) Evolutionary conserved hairpins 50 UTR HP (blue) and 30 UTR HP (red) in the NFIB mRNA sequence.
(B) Drosha CLIP-qRT-PCR of NFIB mRNA from DG NSCs. DGCR8 and Six3 mRNAs were used as positive and negative control CLIP targets, respectively (n = 3
replicates). Mann-Whitney test: *p < 0.05.
(C) Scheme of the psiCheck Renilla Luciferase constructs (rLuc) containing the NFIB 50 UTR HP or 30 UTR HP sequence in the SV40 UTR.
(D) qRT-PCR analysis of rLuc mRNA pulled down with Drosha from psiCheck-NFIB 50 UTR HP and psiCheck-NFIB 30 UTRHP transfected N2a cells relative to the
pull-down from psiCheck-rLuc transfected cells (n = 3 replicates). Two-sided Student’s t test: *p < 0.05, **p < 0.01.
(E) Scheme of the in vitro processing procedure.
(F) Capillary electrophoresis electropherograms of NFIB 30 UTR HP RNA (probe) incubated with the beads alone (ctrl), incubated with mock IP sample, or flag-
tagged Drosha IP (Drosha FLAG IP). Arrow points to degraded 30 UTR HP probe. Loading marker (LM) and probe (P) are indicated.
(G) qRT-PCR analysis of the NFIB 30 UTR HP in control and Drosha cKO NSCs 2 days after adeno-Cre infection.
Data are mean ± SEM.
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http://dx.doi.org/10.1016/j.stem.2016.07.003regulation to NSC maintenance and differentiation. Growing ev-
idence suggest that miRNA-independent functions of the micro-
processor are conserved mechanisms that regulate several6 Cell Stem Cell 19, 1–10, November 3, 2016cellular processes in the nervous system and other tissues
(Chong et al., 2010; Han et al., 2009; Karginov et al., 2010;
Knuckles et al., 2012; Macias et al., 2012).
Figure 4. NFIB Knockdown Rescues Drosha cKO-Induced Oligodendrocyte Differentiation
(A) Quantification of lineage marker expression by NFIB overexpressing DG NSCs after 5-days of differentiation (n = 3 replicates). Mann-Whitney test: *p < 0.05,
***p < 0.001.
(B) Experimental paradigm of the nucleofection experiments.
(C) Quantification of adeno-Cre virus infected (GFP+) mCherry+NG2+ OPCs in Drosha cKO and control NSCs nucleofected with control rLuc esiRNA or NFIB
esiRNA.
(D–F) mCherry+, GFP+, and NG2+ cells in adeno-Cre virus infected control NSC cultures nucleofected with the control esiRNA, Drosha cKO NSCs nucleofected
with the control esiRNA (E), and Drosha cKO NSCs nucleofected with the NFIB esiRNA (F).
(G) Quantification of adeno-Cre virus infected (GFP+) mCherry+btub+ neurons from Drosha cKO and control NSCs nucleofected with rLuc esiRNA or NFIB
esiRNA.
(H) Quantification of adeno-Cre virus infected (GFP+) mCherry+BLBP+ progenitors from Drosha cKO and control NSCs nucleofected with control rLuc esiRNA or
NFIB esiRNA.
Data are mean ± SEM. Biological replicates, n = 3. Kruskal-Wallis with Dunn post hoc test: *p < 0.05, **p < 0.01. The scale bars represent 20 mm.
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progenitors of the adult DG by sustaining NSC potential. Upon
Drosha ablation, DG NSCs are depleted, and gliogenesis in-
creases at the expense of neurogenesis. By comparing Drosha
cKO and Dicer cKO mice, we identified the transcription factor
NFIB as a target of Drosha and showed that the blockade of
NFIB expression is necessary for inhibiting oligodendrocyte for-
mation and enabling neurogenesis in the adult DG. Therefore,
Drosha regulates DG neurogenesis and gliogenesis at least
partially through a miRNA and Dicer-independent, cell-intrinsic
fate program.
CLIP experiments revealed that the microprocessor targets
different RNA classes, including pri-miRNAs, small nucleolar
RNA, long non-coding RNA, and mRNAs (Macias et al., 2012).
Themicroprocessor interactome has been defined in human em-
bryonic stem cells and indicates the importance of cell type and
biological context (Seong et al., 2014). However, it is clear that
several mRNAs are processed by the microprocessor, resulting
in their destabilization (Chong et al., 2010; Johanson et al., 2015;
Knuckles et al., 2012). The non-canonical functions of the micro-
processor represent a rapid and efficient way to influence gene
expression. Our understanding of the mechanisms underlying
these alternative functions of Drosha and the microprocessor
need further investigation. The Drosha-DGCR8 complex is
required for miRNA biogenesis, but it is possible that other
protein-protein interactions underlie the alternate functions of
Drosha (Macias et al., 2015).
DG NSCs are fate committed to glutamatergic granule
neuron and astrocytic fates in vivo (Bonaguidi et al., 2011; Lu-
gert et al., 2010). How this intrinsic fate restriction is controlled
remained unclear. In vitro studies showed that DG NSCs are
able to generate oligodendrocytes only under specific condi-
tions, including co-culture with neurons (Song et al., 2002;
Suh et al., 2007). Furthermore, reprogramming of adult DG
NSCs by Ascl1 overexpression leads to a shift in fate from
neuronal to oligodendrocyte differentiation (Braun et al., 2015;
Jessberger et al., 2008). A potential link between Drosha and
Ascl1 remains to be shown, but Ascl1 mRNA was not cross-
linked immunoprecipitated with Drosha from DG NSCs (data
not shown).
Clonal lineage tracing of DG NSCs in vivo showed symmetric
and asymmetric neuron and astrocytic fates (Bonaguidi et al.,
2011). Drosha cKO NSCs exited the stem cell pool and the cell
cycle and generated few progeny. However, at the population
and single-cell levels, DG NSCs retain the potential to generate
all three cell lineages of the brain, but Drosha mediates the
intrinsic restriction of oligodendrocyte differentiation potential.
NFI transcription factors can activate and repress gene tran-
scription depending on the gene and cellular context (Chang
et al., 2013; Gronostajski, 2000; Messina et al., 2010). NFIB influ-
ences stem cell maintenance and differentiation in several tis-
sues, including in the SVZ, as part of a cross-regulatory network
together with Pax6/Brg1 (Chang et al., 2013; Ninkovic et al.,
2013). In addition, NFIB can repress Notch signaling in embry-
onic hippocampal NSCs by repressing Hes1 promoter activity
(Piper et al., 2010). Therefore, we speculate that induction of
NFIB expression might lead to inhibition of stem cell genes and
block of Notch signaling resulting in exhaustion of the DG NSC
pool and differentiation. Moreover, we also show for the first8 Cell Stem Cell 19, 1–10, November 3, 2016time that NFIB has a central function in regulating oligodendro-
cyte fate commitment in the adult DG. It remains to be shown
which genes are regulated downstream of NFIB. Although we
cannot exclude that NFIB acts as a transcriptional repressor of
genes required for neuronal differentiation and therefore indi-
rectly promotes gliogenesis, NG2 is upregulated in response
to Drosha cKO in an NFIB-dependent manner. Interestingly,
Cspg4 (the gene encoding NG2) has NFI binding motifs that
are bound by NFIB, suggesting a direct regulation in DG NSCs
(Chang et al., 2013). We believe this is the first demonstration
of a non-canonical Drosha-mediated regulation of adult stem
cell fate through a niche-independent intrinsic pathway. In the
future, it will be important to understand the targets of this
post-transcriptional pathway and whether stem cells are able
to modulate Drosha activity to control cell fate in order to satisfy
demand.
EXPERIMENTAL PROCEDURES
Animal Husbandry
The mice used have been described previously (Supplemental Experimental
Procedures). Mice weremaintained on a 12 hr day-night cycle with free access
to food and water under specific pathogen-free conditions and according to
Swiss federal regulations. All procedures were approved by the Basel
Cantonal Veterinary Office (license numbers 2537 and 2538).
Hippocampal NSCCultures, Adenoviral Infection, andNucleofection
DGNSCs were isolated from 8-week-old mice as described previously (Lugert
et al., 2010). DG NSCs were infected with an adeno-Cre adenovirus at a mul-
tiplicity of infection of 100 and fixed after 24 or 48 hr. DG NSC cultures were
nucleofected using a mouse neural stem cell kit (Lonza) (Supplemental Exper-
imental Procedures).
FACS
After TAM induction, NSCs were isolated from Hes5CreERT2Rosa26-
CAG::EGFPfl/+ and Hes5::CreERT2Droshafl/flRosa26-CAG::EGFPfl/+ using a
FACSariaIII (BD Biosciences) (Supplemental Experimental Procedures).
RNA Isolation, qRT-PCR, and Analysis of miRNA Expression
Total RNA was isolated from cultured or sorted DG NSCs using Trizol reagent
(Life Technologies). Analysis of gene expression was performed as described
in Supplemental Experimental Procedures. miRNAs were isolated using mir-
VANA kit (ThermoFisher) following the miRNA enrichment procedure and
quantified by TaqMan arrays (Life Technologies) (Supplemental Experimental
Procedures).
In Vitro Processing of NFIB HP RNAs
In vitro processing was performed on 50 and 30 UTR NFIB HP RNAs as
described previously with minor adaptations (Supplemental Experimental Pro-
cedures) (Lee and Kim, 2007).
50 RACE
50 RACE experiments were performed on 3 mg of total RNA of control and
Drosha cKO NSCs following the manufacturer’s instructions (Invitrogen) (Sup-
plemental Experimental Procedures).
Luciferase Assay
DG NSCs were transduced with an adeno-Cre adenovirus at a multiplicity of
infection of 100 with or without subsequent nucleofection 2 days later with
the psiCheck2 containing the 30 UTR HP or 50 UTR HP or control psiCheck2
vectors (Supplemental Experimental Procedures).
Quantification and Statistical Analysis
Randomly selected, stained cells were analyzed with fixed photomultiplier
settings on a Zeiss LSM510 confocal and Apotome2 microscope. For clonal
Please cite this article in press as: Rolando et al., Multipotency of Adult Hippocampal NSCs In Vivo Is Restricted by Drosha/NFIB, Cell Stem Cell (2016),
http://dx.doi.org/10.1016/j.stem.2016.07.003analysis, the entire hippocampus was sectioned and reconstructed as
described previously (Bonaguidi et al., 2011) (Supplemental Experimental Pro-
cedures). Percentages were converted by arcsine transformation. Statistical
comparisons were conducted by two-tailed unpaired Student’s t test, Mann-
Whitney test, one-way ANOVA, or Kruskal-Wallis with Dunn post hoc test as
indicated. Statistical significance was assessed using GraphPad Prism soft-
ware (GraphPad Software). Significance was established at p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.stem.2016.07.003.
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Figure S1. Drosha cKO from Hes5::CreERT2 expressing NSCs impairs neurogenesis in the DG. (A) 
Overview of the Hes5::CreERT2, Rosa26-CAG::EGFP and floxed Drosha alleles and Cre-mediated gene 
rearrangements (Chong et al., 2008; Harfe et al., 2005; Lugert et al., 2012). TAM treatment induces 
Drosha cKO and constitutive expression of GFP from the Rosa26-CAG::EGFP reporter allele in 
Hes5::CreERT2-expressing cells and their progeny. (B) Twenty-one days after TAM induction, GFP+ 
Hes5-derived cells in control animals express Drosha (white arrowheads) and these include radial 
GFP+GFAP+ NSCs (yellow arrowheads). (C) Twenty-one days after TAM induction, GFP+ Hes5-derived 
cells do not express Drosha in the Drosha cKO (white arrowheads) including Hes5-derived radial 
GFP+GFAP+ (yellow arrowheads). (D) Quantification of Hes5-derived (GFP+) cells at d21 and d100 post-
TAM induction in control and Drosha cKO animals (control n = 5, Drosha cKO n = 5. Two-sided 
  
Student’s t-test, *P<0.05, ***P<0.001). (E) Quantification of radial GFP+GFAP+ cells at d21 post-TAM 
induction in control and Drosha cKO animals (control n = 5, Drosha cKO n = 5. Two-sided Student’s t-
test, *P<0.05). (F and G) NeuN+ mature neurons in control and Drosha cKO animals at d100 post-TAM 
induction. Inset and magnification on the right show an oligodendrocyte in Drosha cKO animals at d100 
post-TAM induction. (H) Quantification of GFP+S100β+ astrocytes and GFP+NeuN+ newborn neurons at 
d100 post-TAM induction in control and Drosha cKO animals (control n = 5, Drosha cKO n = 5. Two-
sided Student’s t-test, *P<0.05). (I and J) S100β+ mature astrocytes in the Drosha cKO compared to 
control animals at d100. (K) TAM induction and kainic acid (KA) treatment regime to study the 
activation of Drosha cKO progenitors after epileptic seizures. TAM was administered once per day for 5 
consecutive days. KA was administered systemically 21 days after TAM induction and the mice analyzed 
4 days later at d25. (L) Quantification of proliferative GFP+PCNA+ progenitors and GFP+DCX+ 
neuroblasts on d4 after KA treatment in control and Drosha cKO animals. (M and N) PCNA+ and DCX+ 
cells in control and Drosha cKO animals on d4 after KA treatment (control n = 3, Drosha cKO n = 4. 
One-way ANOVA with Bonferroni post-hoc test: *P<0.05, ***P<0.001). Data are mean ± SEM. Scale 
bars represent 20 µm in (B), (C), (F), (G), (I) and (J) and represent 100 µm in (M) and (N).  
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Figure S2. Adult hippocampal NSCs produce oligodendrocytes upon Drosha deletion in vivo and in 
vitro. (A) Experimental paradigm of adeno-gfap::Cre stereotactic intracranial injection and gene deletion 
from GFAP+ radial NSCs and analysis at d6 and d21. (B) GFP expression from the recombined Rosa26-
CAG::EGFP allele following adeno-gfap::Cre injection into the DG of Rosa26-CAG::EGFPfl/+ mice. (C) 
GFP and GFAP expression at 6 dpi. (D) Quantification of GFP+GFAP+ and GFP+DCX+ at 6 dpi. (E) 
Quantification of GFP+Olig2+NG2+ cells in the DG of Drosha cKO (Hes5::CreERT2Droshafl/flRosa26-
CAG::EGFPfl/+) and control (Hes5::CreERT2Rosa26-CAG::EGFPfl/+) animals (control n = 3, Drosha 
cKO n = 3. Two-sided Student’s t-test: **P<0.01). (F) Quantification of GFP+Olig2+ and GFP+NG2+ 
cells in Drosha cKO (Hes5::CreERT2Droshafl/flRosa26-CAG::EGFPfl/+) DG NSCs and control 
(Hes5::CreERT2Rosa26-CAG::EGFPfl/+) animals (control n = 3, Drosha cKO n = 3. Two-sided Student’s 
t-test: *P<0.05, **P<0.01). (G) NG2+ and Olig2+ oligodendrocytes in the DG of Drosha cKO 
(Hes5::CreERT2Droshafl/flRosa26-CAG::EGFPfl/+) at d21 post-TAM induction (arrowheads). (H) Clonal 
analysis of GFP expression following low dose TAM administration of Hes5::CreERT2Rosa26-
CAG::EGFPfl/+ mice after 2 days. (I) Quantification of the distance to the nearest GFP+ cell 2 days after 
low dose TAM induction (n = 2 animals). (J) GFP, DCX and GFAP expression following low dose TAM 
administration of Hes5::CreERT2Rosa26-CAG::EGFPfl/+ animals after 21 days. A - astrocyte, N - neuron, 
R - radial glia. The cells of each cell-type in the clone are numbered in the image. (K) GFP, Olig2 and 
GFAP expression following low dose TAM induction of Drosha cKO at d21. A - astrocyte and O - 
oligodendrocyte. The cells of each cell-type in the clone are numbered in the image. (L) GFP, DCX and 
Olig2 expression d15 after retro-Cre virus infection of the DG of Droshafl/flRosa26-CAG::EGFPfl/+ 
animals. (M) Quantification of GFP+DCX and GFP+Olig2 cells d15 after retro-Cre virus infection of the 
DG of Droshafl/flRosa26-CAG::EGFPfl/+ animals. (N and O) GFP and DCX expression after adeno-
gfap::Cre-mediated Dicer cKO (Hes5::CreERT2Dicerfl/flRosa26-CAG::EGFPfl/+) and infected control 
(Hes5::CreERT2Rosa26-CAG::EGFPfl/+) mice. (P) Expression and quantification of BLBP+ and βtub+ 
cells derived from NSCs grown in the presence of mitogens (FGF2 and EGF). (Q) βtub expression by 
cultured DG NSCs upon differentiation induced by mitogen removal and quantification of Sox2, βtub and 
Sox10 expressing cells (Biological replicates n = 2). (R) Experimental paradigm for gene ablation from 
cultured adult DG NSCs with adeno-Cre viruses. (S) Western-blot and quantification of Drosha and Dicer 
protein expression 72 hours after adeno-Cre virus mediated Drosha cKO and Dicer cKO, respectively. (T-
V) βtub expression after adeno-Cre virus mediated Drosha cKO and Dicer cKO compared to control. (W) 
Quantification of GFP+cleavedCASP3+ cells in cultured control, Drosha cKO and Dicer cKO NSCs d4 
post adeno-Cre virus infection (Biological replicates n = 4. Kruskal-Wallis with Dunn post-hoc test: 
*P<0.05). (X) Cells expressing the oligodendrocyte marker Sox10 by Drosha cKO cells 2 days after 
adeno-Cre virus infection. (Y) ΔCT plots of relative miRNA expression profiles of control (y–axis) 
versus Drosha cKO (x–axis) DG NSC cultures 48 hours post adeno-Cre infection. Correlation 
coefficients R2 = 0.81. (Z) ΔCT plots of relative miRNA expression profiles of control (y–axis) versus 
Dicer cKO (x–axis) DG NSC cultures 48 hours post adeno-Cre infection. Correlation coefficients R2 = 
0.66. Data are mean ± SEM. Scale bars represent 200 µm in (B), 100 µm in (H), (P) and (Q), 20 µm in 
(C), (G), (J), (K), (L), (N), (O), (T), (U), (V) and (X).  
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Figure S3. Drosha binds and regulates NFIB mRNA.  (A) Scheme of the crosslinked 
immunoprecipitation (CLIP) procedure. (B) Western-blot for Drosha protein after immunoprecipitation. 
Rabbit IgG and bead-only (no AB) IPs were performed as negative controls. Drosha CLIP-quantitative 
RT-PCR for NFIB and DGCR8 (positive control) mRNAs. Six3 mRNA was used as a negative control 
mRNA in the CLIP experiments. (C) Fragment analyzer electropherograms of NFIB 5’UTR HP RNA 
probe, control incubated with the beads alone (ctrl) as degradation control, with mock IP, or with flag-
tagged Drosha IP (Drosha FLAG IP). Loading marker – LM, full-length probe - P. (D) 5’RACE of NFIB 
3’UTR mRNA in wild-type NSCs. Agarose gel of 5’RACE products of control and Drosha cKO NSCs. 
The diagram represents cleaved fragments identified by Sanger sequencing. Green and black bars identify 
respectively fragments within and distal to the hairpin sequence. Bin size corresponds to 5 nucleotides. 
(E) Scheme of luciferase assay. Rosa26-CAG::EGFPfl/+ (control), Droshafl/flRosa26-CAG::EGFPfl/+ and 
Dicerfl/flRosa26-CAG::EGFPfl/+ DG NSCs were infected with adeno-Cre viruses and subsequently 
transfected with psiCheck-NFIB 5’UTR HP or psiCheck-NFIB 3’UTR HP vectors before quantifying 
luciferase activity. (F) Relative luciferase activity of the psiCheck2 NFIB 5’UTR HP and 3’UTR HP 
vectors in control, Drosha cKO and Dicer cKO DG NSCs (Biological replicates n = 3. One-sided 
Student’s t-test: *P<0.05, **P<0.01). (G) TAM induction regime for fluorescence activated cell sorting 
(FACS) of Hes5::CreERT2-derived cells. TAM was administered to mice once per day for 5 consecutive 
days before FACS for GFP+ cells at 1 day (d1) after induction. The GFP+ population was gated on the 
basis of the GFP-negative population. Quantitative RT-PCR analysis of Drosha and NFIB mRNA levels 
in the FACSorted GFP+ cells from the Drosha cKO (control n = 12, Drosha cKO n = 19. Two-sided 
Student’s t-test: *P<0.05). (H) Scheme of the in vitro deletion assay. Quantitative RT-PCR analysis of 
NFIB and Sox10 expression by Drosha cKO and Dicer cKO NSCs 48 hours after adeno-Cre infection 
(Biological replicates n = 3. Two-sided Student’s t-test: *P<0.05). Data are mean ± SEM. 
  
  
Figure S4, Related to Figure 4 
 
Figure S4. Drosha inhibits oligodendrocyte generation from DG NSCs through NFIB knockdown. 
(A) Gain of NFIB function experiments in cultured DG NSCs. pCMV-NFIB or empty pCMV expression 
vectors were nucleofected into cultured adult DG NSCs. (B) Western-blot analysis of transfected DG 
NSCs blotted for the HA-tagged NFIB (HA1, HA2 are experimental duplicates) compared to empty 
pCMV vector (CMV) and pCMV-GFP vector (GFP) only transfected cells. (C-D) βtub expression by 
pCMV (ctrl: C) and pCMV-NFIB (NFIB: D) transfected DG NSCs after 5 days of differentiation. (E) 
  
Sox10 and NG2 expression by NFIB overexpressing DG NSCs after 5 days of differentiation. (F) 
Quantitative RT-PCR analysis of N2a cells transfected with the control esiRNA (rLuc) and esiRNA 
targeting NFIB. NFIB mRNA is not detectable 24 and 48 hours after esiRNA NFIB transfection 
(Biological replicates n = 3. Mann-Whitney test: ***P<0.001). (G) Expression of the oligodendrocyte 
marker NG2 by control NSCs nucleofected with NFIB esiRNA. (H) Quantification of adeno-Cre infected 
(GFP+), nucleofected mCherry+, GFAP+ astrocytes in Drosha cKO and control NSCs nucleofected with 
control esiRNA (rLuc) or NFIB esiRNAs (Biological replicates n = 3. Kruskal-Wallis with Dunn post-
hoc test: *P<0.05). (I) Under physiological conditions, adult DG NSCs express the RNAseIII Drosha that 
targets NFIB mRNA and inhibits NFIB protein expression. DG Hes5+ NSCs (type-1) produce DCX+ 
neuroblasts via intermediate progenitors (IP) that mature into NeuN+ granule neurons, but do not generate 
oligodendrocytes. (J) After Drosha deletion from adult DG NSCs, NFIB mRNA is up regulated. NFIB 
expression drives NSCs into oligodendrocyte differentiation at the expense of neuron production. RBP, 
RNA binding protein. Scale bars represent 20 µm in (C), (D), (E) and (G). Data are mean ± SEM. 
  
  
Table S1, Related to Figure 1 and S1 
 
 
Table S1: Density of GFP+ marker expressing cells in the adult DG in vivo. Table showing the density 
of GFP+ cells expressing specific markers at d21 and d100 post-TAM induction and the density of GFP+ 
cells expressing DCX and PCNA d21 after kainic acid (KA) administration in control and Drosha cKO 
animals. Values are mean ± SEM.  
  Mean ± SEM (GFP+ cells/mm2) 5d Tamoxifen + 21d chase   
 GFP+      Sox2+S100β- PCNA+ DCX+ radial GFAP+ 
Control 838.7 ± 65.3 398.0 ± 26.1 168.2 ± 17.8 444.3 ± 64.6 371.7 ±  65.5  
Drosha cKO 577.5 ± 46.4  209.0 ± 34.1 60.5 ± 16.1 269.5 ± 34.3 119.4 ± 30.9 
P-values  
(two-sided t-test) 
0.03 (*) 
 
0.01 (*) 0.002 (**) 0.04 (*) 0.02 (*) 
  
           Mean ± SEM (GFP+ cells/mm2) 5d Tamoxifen + 100d chase 
 
 
 GFP+ Sox2+S100β+ NeuN+  DCX+ radial GFAP+ 
Control  969.0 ± 52.4 6.4 ± 0.4 455.7 ± 57.5 284.9 ± 19.1 174.2 ± 47.7 
Drosha cKO 625.3 ± 23.9 29.8 ± 1.8 177.3 ± 51.2 84.9 ± 19.4 43.2 ± 17.8 
P-values 
(two-sided t-test) 
0.003 (**) 0.002 (***) 0.02 (*) 0.0004 (***) 0.004 (**) 
  
           Mean ± SEM (GFP+ cells/mm2) 5d Tamoxifen + 21d chase + KA 
 
 GFP+ DCX+ PCNA+ 
Control  955.6 ± 53.8 590.3 ± 7.7 257.4 ± 5.4 
Drosha cKO 530.0 ± 40.4  121.4 ± 15.8      68.2 ± 10.9 
P-values (one-
way ANOVA) 
0.003 (**)  0.00004 (***)    0.0003 (***) 
  
Table S2, Related to Figure 2 
 
 Mean ± SEM (GFP+ cells/mm2) 
adeno-gfap::Cre + 21dpi 
  
 DCX+ Sox10+ 
Control       427.8 ± 85.1 5.3 ± 2.1 
Drosha cKO 141.8 ± 34.5 127.8 ± 39.7 
Dicer cKO 247.9 ± 40.7 32.1 ± 6.4 
P-values (one-way ANOVA + Bonferroni Post-
Hoc) ctrl vs. Drosha cKO 
P-values (one-way ANOVA + Bonferroni Post-
Hoc) ctrl vs. Dicer cKO 
0.03 (*) 
 
0.2 (ns) 
0.0062 (**) 
 
0.5 (ns) 
 Sox2+ PCNA+ 
Control 991.3 ± 80.4 259.2 ± 26.0 
Drosha cKO 450.3 ± 116.7 39.3 ± 22.1 
P-values (two-sided t-test) 0.01 (**) 0.003 (**) 
 
Table S2: Density of GFP+ marker expressing cells in the adult DG in vivo following adeno-
gfap::Cre adenoviral infection. Table showing the density of GFP+ cells expressing specific markers 
d21 after adeno-gfap::Cre adenovirus infection in control and Drosha cKO animals. Values are mean ± 
SEM, ns – not significant. 
  
  
Table S3, Related to Figure 2 
 
 Mean ± SEM (% GFP+ cells)  
adeno-Cre + 2 dpi 
 
 
 BLBP+ NG2+ βtub+ GFAP+ aCASP3+ 
Control  47.7 ± 6.7 0 ± 0 46.3 ± 5.1 18.6 ± 3.4 1.6 ± 0.8 
Drosha cKO  17.4 ± 5.1 37.7 ± 7.2 22.1 ± 2.2 1.6 ± 1.2 2.4 ± 1.4  
Dicer cKO 42.4 ± 5.7 4.7 ± 2.2 23.4 ± 3.6 16.6 ±1.3 4.7 ± 0.9 
P-values (Kruskal-Wallis 
test) Ctrl vs. Drosha 
 
0.03 (*) 
 
 
0.001 (**) 
 
 
0.0029 (**) 
 
 
0.0011 (**) 
 
 
0.99 (ns) 
 
P-values (Kruskal-Wallis test) 
Ctrl vs. Dicer cKO 
0.99 (ns) 0.27 (ns) 0.0037 (**) 0.99 (ns) 0.04 (*) 
 
Table S3: Distribution of GFP+ marker expressing cells in adult DG NSCs in vitro following adeno-
Cre-mediated recombination. Table showing the distribution of GFP+ cells expressing specific markers 
2 days after adeno-Cre adenoviral infection of control, Drosha cKO and Dicer cKO DG NSCs in vitro. 
Values are mean ± SEM, ns – not significant. 
  
  
Table S4, Related to Figure 4 and Figure S4 
 
 Mean ± SEM  
(% mCherry+GFP+ cells) 
adeno-Cre + 2 dpi 
 
 NG2+ BLBP+ βtub+ GFAP+ 
Control + esiRNA rLuc 2.2 ± 1.8 47.8 ± 3.7 46.9 ± 4.4 14.7 ± 1.5 
Drosha cKO + esiRNA rLuc 64.4 ± 10 24.6 ± 2.8 25.6 ± 2.9 6.7 ± 0.8 
Control + esiRNA NFIB 4.7 ± 4.7 52.4 ± 7 46.5 ± 1.9 13.3 ± 0.8 
Drosha cKO + esiRNA NFIB 23.1 ± 2.6 48.1 ± 4.5 45.7 ± 4.9 6.3 ± 1.3 
P-values (Kruskal-Wallis test) 0.001 (**) 0.006 (**) 0.005 (**) 0.003 (**) 
 
Table S4: Distribution of GFP and mCherry expressing cells in adult DG NSCs following NFIB 
knockdown in vitro. Table showing the distribution of GFP+ marker expressing cells after NFIB 
knockdown and 2 days after adeno-Cre adenoviral infection of control and Drosha cKO DG NSCs in 
vitro. Values are mean ± SEM. 
  
Supplemental Experimental Procedures 
Transgenic animals 
Hes5::CreERT2, Rosa26-CAG::EGFP, Droshafl/fl, Dicerfl/fl mice have been described elsewhere (Chong et 
al., 2008; Harfe et al., 2005; Lugert et al., 2012; Tchorz et al., 2012). All mice were maintained on a 
C57BL6 background and were 8-10 weeks old at the onset of the experiments. CreERT2-recombinase 
activity from the Hes5CreERT2 locus was induced by Tamoxifen administration (Sigma; 2 mg/injection in 
corn oil) injected as a single dose intraperitoneal daily for five consecutive days. For in vivo clonal 
analysis animals received one single injection of Tamoxifen (48 mg/kg in corn oil).  
Tissue preparation and immunohistochemistry 
Mice were deeply anesthetized by injection of a ketamine/xylazine/acepromazine solution (150 mg, 7.5 
and 0.6 mg per kg body weight, respectively). Animals were perfused with ice-cold 0.9% saline followed 
by 4% paraformaldehyde in 0.1M phosphate buffer. Brains were isolated and post-fixed overnight in 4% 
paraformaldehyde in 0.1M phosphate buffer, and then cryoprotected with 30% sucrose in phosphate 
buffer at 4°C overnight. Brains were embedded and frozen in OCT (TissueTEK) and sectioned as 30 µm 
floating sections by cryostat (Leica). Free-floating coronal sections were stored at -20°C in antifreeze 
solution until use. For clonal analysis, coronal brain sections (45 µm) through the entire dentate gyrus 
were maintained in series. 
Sections were incubated overnight at room temperature, with the primary antibody diluted in blocking 
solution of 1.5% normal donkey serum (Jackson ImmunoResearch), 0.5% Triton X-100 in phosphate-
buffered saline. For clonal analysis, sections where incubated for 48 hours at 4°C, with primary antibody 
in blocking solution of 1.5% normal donkey serum (Jackson ImmunoResearch), 2% Triton X-100 in 
phosphate-buffered saline. Antibodies used: AN2 (1:5, gift of Prof. M. Trotter), activated cleavedCASP3 
(Cell Signalling, rabbit, 1:500), BLBP (Chemicon, rabbit, 1:500), βtubulinIII (Sigma, mouse, 1:500), 
DCX (Santa Cruz, goat, 1:500), Drosha (Abcam, rabbit, 1:100), dsRed (Clonetech, rabbit, 1:500), GFAP 
(Sigma, mouse, 1:1000; Santa Cruz, goat, 1:500), GFP (AbD Serotec, sheep, 1:250; Invitrogen, rabbit, 
1:700; AvesLabs, chicken, 1:500), NeuN (Millipore, mouse, 1:1000), NG2 (Chemicon, rabbit, 1:500), 
Olig2 (Millipore, rabbit, 1:500), PCNA (DAKO, mouse, 1:1000), S100β (Sigma, mouse, 1:200), Sox2 
(Santa Cruz, goat, 1:500), Sox10 (Santa Cruz, goat, 1:500). 
Sections were washed in phosphate-buffered saline and incubated at room temperature for 2 hours with 
the corresponding secondary antibodies in blocking solution. For clonal analysis sections where incubated 
for 24 hours at 4°C with the corresponding secondary antibody in blocking solution.  Secondary 
antibodies and detection: Alexa488/Cy3/Alexa555/Alexa594/Alexa647/Alexa649 conjugated anti-
chicken, mouse, goat, rabbit, rat and sheep immunoglobulin (1:500, Jackson Immunoresearch). Sections 
were then washed and counter-stained with DAPI (1 µg/ml). For PCNA and Drosha detection, antigens 
were recovered at 80 °C for 20 minutes in sodium citrate solution (10 mM, pH7.4). Stained sections were 
mounted on Superfrost glass slides (Thermo Scientific), embedded in mounting medium containing 
diazabicyclo-octane (DABCO; Sigma) as an anti-fading agent and visualized using a Zeiss LSM510 
confocal microscope, Leica SP5 confocal microscope or Zeiss Apotome2 microscope. 
Adeno-gfap::Cre adenoviral and retro-Cre retrovirus infections in the adult DG 
Adult (8-10 week old) mice (Rosa26-CAG::EGFPfl/+, Droshafl/flRosa26-CAG::EGFPfl/+, Dicerfl/flRosa26-
CAG::EGFPfl/+) were anesthetized in a constant flow of Isofluorane (3%) in oxygen and positioned in a 
stereotaxic apparatus (David Kopf instruments). Mice were injected with Temgesic subcutaneous (0.05 
mg/kg body weight). The skull was exposed by an incision in the scalp and a small hole (1 mm) drilled 
through the skull. One µl of adeno-gfap::Cre adenovirus (titer 1x1012 infectious particles per ml) or 
retrovirus-Cre (titer 2.7x107, Braun et al., 2015) was injected in the DG using a sharpened borosilicate 
glass capillaries at the stereotaxic coordinates -2 mm anteroposterior, 1.5 mm lateral to Bregma and -2.0 
mm below the surface of the skull. Mice were killed 6, 15 or 21 days after virus infection. Brain tissue 
was processed and analyzed by immunohistochemistry as described above. 
Induction of epileptic seizures  
Seizures were induced as described previously (Lugert et al., 2010), kainic acid (KA, Tocris Bioscience) 
was administered intraperitoneal at 30 mg/kg body weight. Seizures developed within 45 minutes after 
injection and spontaneously stopped within 2-3 hours. The mice were sacrificed 4 days after KA injection 
and the brains processed for immunohistochemical analysis as described above. 
Hippocampal neural stem cell cultures 
Brains of 8-week old Rosa26-CAG::EGFPfl/+, Droshafl/flRosa26-CAG::EGFPfl/+, Dicerfl/flRosa26-
CAG::EGFPfl/+ mice were isolated in L15 Medium (GIBCO) and sectioned live at 300 µm using a 
  
McIllwains tissue chopper. The DG was micro-dissected from the rest of the hippocampus under a 
dissection binocular microscope avoiding contamination with tissue from the molecular layer, cerebral 
cortex and subventricular zone, digested in a Papain based solution and mechanically dissociated as 
described previously (Lugert et al., 2010). Cells were plated in 48-well dishes (Costar) coated with 100 
µg/ml Poly-L-Lysine (Sigma) and 1 µg/ml Laminin (Sigma) in neural progenitor culture medium: 
DMEM:F12 (Gibco, Invitrogen), 2% B27 (Gibco, Invitrogen), FGF2 20 ng/ml (R&D Systems), EGF 20 
ng/ml (R&D Systems). DG NSCs were differentiated by growth factor removal and continued culture. 
Cells were fixed for 10 minutes in 4% paraformaldehyde in 0.1M phosphate buffer and processed as 
described above. 
Adeno-Cre adenovirus infection and AMAXA nucleofection in vitro 
Rosa26-CAG::EGFPfl/+, Droshafl/flRosa26-CAG::EGFPfl/+, Dicerfl/flRosa26-CAG::EGFPfl/+ DG NSCs 
were transduced with an adeno-Cre adenovirus (titer 1x1011 infectious particles per ml) in growth factor 
free medium and plated at a density of 5x104 cells/cm2 on poly-L-Lysine/Laminin coated coverslips. 48 
hours later, the cells were fixed in 4% paraformaldehyde in 0.1M phosphate buffer and process as 
described above. For western-blot experiments, Rosa26-CAG::EGFPfl/+, Droshafl/flRosa26-
CAG::EGFPfl/+, Dicerfl/flRosa26-CAG::EGFPfl/+ DG NSCs were transduced with an adeno-Cre 
adenovirus (titer 1x1011 infectious particles per ml) and collected in lysis buffer after 72 hours and 
processed for western-blot (see below)  
Rosa26-CAG::EGFPfl/+ and Droshafl/flRosa26-CAG::EGFPfl/+ adult DG NSC cultures were nucleofected 
according to the mouse neural stem cell kit instructions (Lonza). Briefly, DG NSCs were dissociated with 
trypsin and resuspended in the nucleofector solution to a final concentration of 106 cells/100µl. Cell 
suspensions were combined with either 100 pmol endoribonuclease-prepared siRNAs (esiNA) against 
NFIB or Renilla luciferase (Sigma). pCAG::mCherry was added at a ratio 1:3 to identify transfected 
NSCs. For overexpression, DG NSCs were combined with either pCMV (empty) or pCMV-HA-NFIB 
(kindly provided by Prof. Heiner Schrewe) vectors and pmaxGFP. NSCs were nucleofected with a 
Nucleofector 2b device (program A-033). NSCs were immediately transfer to neural progenitor culture 
medium and plated at the density of 5x104 cells/cm2 on poly-L-Lysine/Laminin coated coverslips. 24 
hours later, DG NSCs were transduced with an adeno-Cre adenovirus (titer 1x1011 infectious particles per 
ml) in growth factor free medium and fixed 2 dpi. For overexpression, DG NSCs were fixed 2 days post-
nucleofection. 
Fluorescence activated cell sorting  
Hes5::CreERT2Rosa26-CAG::EGFPfl/+ and Hes5::CreERT2Droshafl/flRosa26-CAG::EGFPfl/+ animals 
were induced with TAM for five consecutive days and brains collected 1 day after the last injection. 
NSCs were isolated as described above. Cells were washed with L15 medium (Gibco, Invitrogen), 
filtered through a 40 µm cell sieve (Miltenyi Biotec) and sorted by forward and side-scatter for live cells 
(control) and gated for GFP-negative (wild type levels) or GFP+ populations with a FACSaria III (BD 
Biosciences). DAPI (5 mg/ml) was added to discriminate living NSCs. GFP+ cells were used for RNA 
isolation and gene expression analysis (see below). 
RNA Isolation and quantitative RT-PCR 
Total RNA was isolated using the Trizol method (Life Technologies) and resuspended in water. RNA was 
treated with RNase-free DNase I (Roche) to remove genomic DNA contamination. First-strand cDNA 
was generated using BioScript (Bioline) and random hexamer primers followed by quantitative PCR 
using SensiMix SYBR kit (Bioline). Expression analysis of genes of interest was performed on a Rotor-
Gene Q (Qiagen). Primers for quantitative RT-PCR were:  
NFIB (Forward: CAGGAGCAAGATTCTGGAC; Reverse: GGGTGTTCTGGATACTCTCAC); 
NFIB 3’UTR HP (Forward: TAAGTCCTTCAGCCCTTGGA ; Reverse: 
CTGAGGAGGCTGCAGCTAAG) 
Sox10 (Forward: AGCTCTGGAGGTTGCTGAAC; Reverse: GCCGAGGTTGGTACTTGTAGTC); 
Drosha Exon9-10 (Forward: GACGACGACAGCACCTGTT; Reverse: 
GATAAATGCTGTGGCGGATT); 
DGCR8 (Forward: GGAGCTAGATGAAGAAGGAACAGG; Reverse: 
GTAAAGCGTCCACATCATTGTCAA); 
Six3 (Forward: TCAGCAGAGTCACCGTCCAC; Reverse: TGGAGGTTACCGAGAGGATCG) 
βactin (Forward: AGGTGACAGCATTGCTTCTG; Reverse: GGGAGACCAAAGCCTTCATA) 
Analysis of miRNA expression 
Total RNA was isolated from adeno-Cre adenovirus infected Rosa26-CAG::EGFPfl/+, Droshafl/flRosa26-
CAG::EGFPfl/+, Dicerfl/flRosa26-CAG::EGFPfl/+ DG NSCs at 2 dpi using the mirVANA isolation kit 
following the miRNA enrichment procedure. miRNA profiling was performed on TaqMan arrays (Life 
  
Technologies) with 500 ng of purified RNA according to manufacturer’s instructions. Expression analysis 
was performed using the comparative cycle threshold (Ct) values. 
 
Crosslinking and immunoprecipitation  
N2a cells (ATCC) were transfected using Transfectin Lipid Reagent (BioRad) according to 
manufacturer’s instructions with p3X-FLAG-CMV (Sigma) or pCK-Drosha-WT-FLAG (Han et al., 
2009; Knuckles et al., 2012) together with psiCheck2 vectors containing the NFIB hairpins. The 
transfected cells were trypsinized and collected after 48 hours. The mouse NFIB 5’ and 3’ untranslated 
regions of 200bp fragments containing the hairpins were amplified by PCR and cloned into the NotI site 
of psiCheck2 vector (Promega). The cells were cross-linked with 0.5% paraformaldehyde in PBS for 10 
minutes, the reaction was quenched by adding Glycine to a final concentration of 140 mM and the cells 
were lysed by sonication (10 pulses for 10 seconds). Immunoprecipitation was performed for 2 hours at 
4°C using anti-Flag M2 Affinity Gel (Sigma-Aldrich). After washing with lysis buffer, the complexes 
were reverse cross-linked at 70°C for 1 hour. RNA was extracted using Trizol reagent (Invitrogen) 
according to the manufacturer´s instructions and processed as described above. 
Primers: psiCheck2 (Forward: TGATCGGAATGGGTAAGTCC; Reverse: 
GGCCTTGATCTTGTCTTGGT). 
Luciferase Assay 
Rosa26-CAG::EGFPfl/+, Droshafl/flRosa26-CAG::EGFPfl/+ and Dicerfl/flRosa26 CAG::EGFPfl/+ DG NSCs 
were transduced with adeno-Cre or adeno-GFP adenoviruses (see Adeno-Cre infection). 48 hours later, 
the NSCs were nucleofected with the psiCheck2 containing the 3’UTR or 5’UTR NFIB hairpins (see 
Crosslinking and Immunoprecipitation) using the AD1 Primary Cell 4D-Nucleofector Y Kit (Lonza) and 
program EH158. 24 hours post-nucleofection, luciferase activity was measured in a Centro LB 960 
Microplate Luminometer (Berthold) using the Dual-Luciferase Reporter Assay System (Promega). 
Endogenous CLIP in DG NSCs 
A confluent 10 cm dish of DG NSCs was cross-linked at 254 nm at 300 mJ/cm2 in a BioLink UV-
Crosslinker. Cells were lysed with RIPA buffer (0.1M sodium phosphate pH 7.2, 150 mM sodium 
chloride, 0.1% SDS, 1% sodium deoxycholate, 1% NP-40) containing complete protease inhibitor 
cocktail (Roche) and afterwards treated with RNase-free DNase I (Roche). Immunoprecipitation was 
performed with Protein G Sepharose 4 Fast Flow (GE Healthcare Life Science). Rabbit anti-Drosha 
Antibody (1:200; D28B1; Cell Signaling) was coupled to the beads for 1 hour at RT, beads were washed 
three times with RIPA and immunoprecipitation was performed for 2 hours at 4°C. After washing the 
beads with RIPA buffer, the proteins were digested with 4 mg/ml recombinant PCR grade Proteinase K 
(Roche) for 1 hour at 37°C with shaking at 1000 rpm. First-strand cDNA synthesis and quantitative RT-
PCR was performed as above. 
Immunoprecipitation and Western-blot  
Beads from the endogenous Drosha immunoprecipitation were resuspended in Lämmli-Buffer containing 
2-mercaptoethanol, boiled for 5 minutes and collected at 12000 x g for 20 seconds. Protein samples were 
separated on 10% SDS-polyacrylamide gels and transferred to Immobilon-P membranes (Millipore). 
Primary antibody rabbit anti-Drosha (1:1000; D28B1, Cell Signaling), as secondary antibody HRP-
conjugated anti-rabbit IgG (1:10000; Jackson ImmunoResearch). Detection was by chemiluminescence 
(ECL, GE Healthcare). To determine Drosha and Dicer protein expression, Rosa26-CAG::EGFPfl/+, 
Droshafl/flRosa26-CAG::EGFPfl/+, Dicerfl/flRosa26-CAG::EGFPfl/+ DG NSCs were transduced with 
adeno-Cre adenovirus. 24 or 72 hours after infection, the cells were lysed in RIPA Buffer. The lysates 
were incubated 30 minutes on ice and clarified by centrifugation at 13,000 rpm for 20 minutes. Cell 
pellets were resuspended in Lämmli-Buffer 3X. Equal amount of protein were separated by 8% SDS-
polyacrylamide gel and transferred to Immobilon-P membranes (Millipore). Primary antibodies: anti-HA 
tag (1:1000; mouse, Covance), anti-Dicer (1:300; rabbit, Sigma), anti-Drosha (1:1000; rabbit, Cell 
Signaling) and anti-GAPDH (6C5) (1:10000; mouse, Calbiochem). Secondary antibodies HRP-
conjugated anti-rabbit IgG (1:10000; Jackson ImmunoResearch) and HRP-conjugated anti-mouse IgG 
(1:10000; Jackson ImmunoResearch). Detection was by chemiluminescence (ECL, GE Healthcare) and 
quantification by densitometry using ImageJ software (National Institutes of Health, USA). 
In vitro processing 
In vitro processing experiments were performed as described previously with some adaptations (Lee and 
Kim, 2007). Briefly, N2a cells were transfected with pCMV Drosha-Flag or pCMV (empty) vectors. One 
day after transfection, total cell extracts were prepared in lysis buffer (20mM Tris-HCl, pH 7.8, 100mM 
KCl, 0.2mM EDTA, 20% (v/v) glycerol, 1mM PMSF) by sonication followed by RNaseA (Sigma) and 
DNaseI (Roche) treatment and centrifugation at 13400 g for 15 minutes. Total extracts were used for 
  
immunoprecipitation in lysis buffer using Dynabead protein G (Life Technologies) coupled to mouse 
anti-Flag antibody (1:100, Sigma). 30 µl of the processing reaction were prepared and contained: 15 µl of 
beads from Drosha-Flag immunoprecipitated or uncoupled bead fraction, 6.4 mM MgCl2, 0.75 µl RNase 
Inhibitor (Invitrogen) and 0.5-1 µg RNA probe containing the 5’ UTR or 3’UTR NFIB hairpins 
transcribed with T7 RNA polymerase (NEB). The reaction was carried out at 25°C for 30 minutes. RNA 
was extracted using phenol/chloroform and subsequently analyzed on a fragment analyzer using the 
DNF-472 kit (AATI) and the Low Range ssRNA ladder (NEB). 
 
5’ RACE 
5’ RACE experiments were performed on control and Drosha cKO embryonic NSCs according to 
5’RACE System for rapid amplification of cDNA ends version 2.0 kit instructions (Invitrogen). 3 µg of 
total RNA of control and Drosha cKO NSCs were used. Nested PCR products were cloned into pGEM-T 
easy vector (Promega) and sequenced by Sanger sequencing (Microsynth). Fragments were aligned to 
NFIB sequence using DNASTAR Lasergene. 
NFIB RT Primer: AGATCTGTCAATACGAGAA 
NFIB 1 Primer: GTTTTCCTAGCCTACCTGGCATT 
NFIB nested Primer: TGCCTCTTTGTCTCTACGATGC 
In vivo clonal analysis 
Confocal images were used to confirm GFP+ cell identity according to immunohistological and 
morphological properties. Whole hippocampi were serially imaged. For 3D reconstruction, optical stacks 
from the entire DG were serially aligned using Reconstruct 1.1.0 software (Fiala, 2005). Reconstructed 
hippocampi were analyzed with Imaris Software (Bitplane) with the spot detection tool and manually 
refined to mark single NSC in the DG. Single cell coordinates were obtained and analyzed using an in-
house MATLAB script (The MathWorks, Inc.) in order to get the distance to the nearest GFP+ cell 
neighbor (mean: 184.3 ± 17.2 µm, at 2 days after Tamoxifen injection). 
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